tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Roanna Ruiz, 38 are a BUY (63.33%), 22 are a HOLD (36.67%).
Analyst Roanna Ruiz, carries an average stock price target met ratio of 49.36% that have a potential upside of 40.79% achieved within 259 days.
Roanna Ruiz’s has documented 115 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on XERS, Xeris Pharmaceuticals.
Analyst best performing recommendations are on MYOV (MYOVANT SCIENCES LTD).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/9/2021. The price target of $92 was fulfilled within 1 day with a profit of $2.36 (2.5%) receiving and performance score of 25.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2026
$27
$16.97 (169.19%)
$24
3 months 3 days ago
(11-Jun-2026)
0/5 (0%)
$18.48 (216.90%)
Buy Since 14-Sep-2022
$21
$10.97 (109.37%)
$20
3 months 11 days ago
(03-Jun-2026)
0/6 (0%)
$12.23 (139.45%)
Buy Since 21-Sep-2020
$20
$9.97 (99.40%)
$15
6 months 10 days ago
(04-Mar-2026)
1/9 (11.11%)
$10.44 (109.21%)
128
Buy Since 11-Mar-2021
$18
$7.97 (79.46%)
$14
6 months 21 days ago
(24-Feb-2026)
0/19 (0%)
$8.51 (89.67%)
Buy Since 03-Sep-2025
$18
$7.97 (79.46%)
$12
6 months 21 days ago
(24-Feb-2026)
0/2 (0%)
$8.51 (89.67%)
Which stock is Roanna Ruiz most bullish on?
Which stock is Roanna Ruiz most reserved on?
